| 6/22/10 |
TriLink Awarded SBIR Phase II Grant: Chemical Determinants of DNA Ligase Fidelity | Details
The National Institutes of Health recently awarded TriLink a Phase II SBIR Grant of approximately $725,000 to continue their work on developing reagents to enhance the specificity of DNA ligase. |
| 5/11/10 |
TriLink Launches New Website and OligoBuilder® | Details
TriLink announced the launch of its new website and OligoBuilder® online oligonucleotide ordering system. TriLink’s in-house marketing and design team utilized extensive user feedback and survey results to design a customer-centric website.
|
| 4/15/10 |
TriLink Announces Supply Agreement with ETS Laboratories | Details
TriLink signed an agreement with ETS Laboratories (ETS) to supply CleanAmp™ dNTPs for use in their Scorpions™ Wine Spoilage Detection System. |
| 4/9/10 |
TriLink Expands Customized Nucleic Acid Product Line to Canadian Market| Details
TriLink has entered into an agreement with Cedarlane Corporation, a Canadian based research biotechnology company, for the sale and distribution of its modified nucleoside triphosphates, custom chemistry and oligonucleotide products.
|
| 4/1/10 |
Featured in Gen News > New qPCR Workflows Accelerate Discovery | Details
Reducing Cycling Time and Improving Accuracy Are among the Benefits
|
| 1/21/10 |
TriLink Announces Distribution Agreement with Nacalai USA, Inc. | Details
TriLink has signed a distribution agreement with Nacalai USA, Inc., a San Diego based manufacturing and marketing company, for the distribution of TriLink’s modified nucleic acid products in Japan, Singapore, South Korea and Taiwan.
|
| 1/11/10 |
TriLink Announces Distribution Agreement with tebu-bio SA | Details
TriLink has signed a distribution agreement permitting tebu-bio SA (tebu) to sell its CleanAmp™ products. tebu-bio is a European based distributor that supplies over 750,000 reagents and lab services from manufacturers worldwide.
|
| News Archive |
|
